BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Queensland Health
Express Scripts
Mallinckrodt
US Army
Argus Health
QuintilesIMS
Healthtrust
Boehringer Ingelheim
Deloitte

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019882

« Back to Dashboard

NDA 019882 describes TECHNESCAN MAG3, which is a drug marketed by Mallinkrodt Nuclear and is included in one NDA. It is available from one supplier. Additional details are available on the TECHNESCAN MAG3 profile page.

The generic ingredient in TECHNESCAN MAG3 is technetium tc-99m mertiatide kit. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m mertiatide kit profile page.
Summary for 019882
Tradename:TECHNESCAN MAG3
Applicant:Mallinkrodt Nuclear
Ingredient:technetium tc-99m mertiatide kit
Patents:0
Suppliers and Packaging for NDA: 019882
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TECHNESCAN MAG3 technetium tc-99m mertiatide kit INJECTABLE;INJECTION 019882 NDA MALLINCKRODT NUCLEAR MEDICINE LLC 69945-096 69945-096-20 5 VIAL in 1 CELLO PACK (69945-096-20) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthN/A
Approval Date:Jun 15, 1990TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Healthtrust
Colorcon
Novartis
QuintilesIMS
Queensland Health
Accenture
Chinese Patent Office
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot